Status:
UNKNOWN
Rhomboid Intercostal and Subserratum Plane Block for Minimally Invasive Esophagectomy
Lead Sponsor:
Luo Fuchao
Conditions:
Esophagus Cancer
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The objective is to investigate the safety and effectiveness of rhomboid intercostal and subserratum plane (RISS) block for postoperative analgesia after minimally invasive McKeown esophagectomy (MIE-...
Detailed Description
Rhomboid intercostal and subserratum plane block (RISS) is a nerve block technique in which local anesthetics are injected into the rhomboid-intercostal muscle planes and the serratus anterius-interco...
Eligibility Criteria
Inclusion
- Patients received MIE-McKeown surgery and were confirmed by postoperative pathology; Age 18-75 years old
- body mass index (BMI) : 18.5\~23.9kg/m2;
- American Society of Anesthesiologists (ASA) grade: Ⅰ\~Ⅱ;
- Clear consciousness, no cognitive impairment;
- Patients informed to participate in the study and signed informed consent.
Exclusion
- Infection of the puncture site, abnormal platelet or coagulation function;
- Patients with drug allergy involved in this study;
- Long-term use of analgesic, sedative drugs or a history of heavy drinking;
- Patients with chronic painful diseases;
- With severe heart, liver, kidney and lung dysfunction;
- Infectious diseases, blood, immune, circulatory system diseases; -Communication barriers, can not cooperate with the scale assessment; -
- Other situations not suitable for this study.
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06092944
Start Date
March 1 2023
End Date
December 30 2024
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FulingCH
Chongqing, China